home / stock / rcm / rcm articles
NEW YORK, Oct. 29, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigati...
NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential sec...
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigati...
LOS ANGELES, Oct. 20, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises R1 RCM Inc. ("RCM" or "the Company") (NASDAQ:RCM) investors that the...
ATLANTA, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether R1 RCM Inc. ("RCM" or "the Company") (NASDAQ:RCM) c...
BOSTON, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Block & Leviton is investigating R1 RCM, Inc. (NASDAQ:RCM) for potential securities law violations...
MURRAY, Utah, Oct. 16, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the p...
News, Short Squeeze, Breakout and More Instantly...
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended ...
2024-07-09 09:00:05 ET George Hill from Deutsche Bank issued a price target of $16.00 for RCM on 2024-07-09 07:36:00. The adjusted price target was set to $16.00. At the time of the announcement, RCM was trading at $12.66. The overall price target consensus is at $19.00 ...
2024-07-08 09:30:06 ET Morgan Stanley analyst issues OVERWEIGHT recommendation for RCM on July 8, 2024 07:50AM ET. The previous analyst recommendation was Overweight. RCM was trading at $10.95 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...